What can occur if two drugs require cytochrome P450 metabolism at the same time?

What can occur if two drugs require cytochrome P450 metabolism at the same time?

• A. Reduced efficacy of both drugs
• B. Delayed metabolism of both drugs
• C. Increased risk of drug toxicity
• D. Increased elimination of drugs

Answer: (C)

When two drugs that require cytochrome P450 metabolism are administered simultaneously, there is a significant interaction that can result in an increased risk of drug toxicity. This happens because the cytochrome P450 enzyme system can become saturated or inhibited when multiple drugs are competing for metabolism. As a result, the usual metabolic pathways may be overwhelmed, leading to slower degradation of one or both drugs. Consequently, drug levels in the body may rise to a point where they exceed the therapeutic window, potentially causing toxic effects. The cytochrome P450 system plays a key role in the metabolism of many medications, and its activity can be influenced by various factors, including the presence of other drugs. When two substances rely on the same metabolic enzymes, the competition effectively prolongs the duration of action and enhances the concentration of active drug in the system, thereby increasing the likelihood of toxicity. This situation underlines the importance of understanding drug interactions, particularly for medications that have narrow therapeutic ranges. While other options discuss reduced efficacy, delayed metabolism, or increased elimination of drugs, these do not encompass the most critical and immediate concern associated with parallel metabolism through the cytochrome P450 system, which is the heightened risk of adverse effects due to elevated drug levels.

When two drugs that require cytochrome P450 metabolism are administered simultaneously, there is a significant interaction that can result in an increased risk of drug toxicity. This happens because the cytochrome P450 enzyme system can become saturated or inhibited when multiple drugs are competing for metabolism. As a result, the usual metabolic pathways may be overwhelmed, leading to slower degradation of one or both drugs. Consequently, drug levels in the body may rise to a point where they exceed the therapeutic window, potentially causing toxic effects.

The cytochrome P450 system plays a key role in the metabolism of many medications, and its activity can be influenced by various factors, including the presence of other drugs. When two substances rely on the same metabolic enzymes, the competition effectively prolongs the duration of action and enhances the concentration of active drug in the system, thereby increasing the likelihood of toxicity. This situation underlines the importance of understanding drug interactions, particularly for medications that have narrow therapeutic ranges.

While other options discuss reduced efficacy, delayed metabolism, or increased elimination of drugs, these do not encompass the most critical and immediate concern associated with parallel metabolism through the cytochrome P450 system, which is the heightened risk of adverse effects due to elevated drug levels.